Technology solution designed to combat the spread of virus and ensure proper care of those impacted
To help hospitals and health systems meet the potential patient-surge associated with COVID-19 outbreaks across the country, QliqSOFT,Inc. today announced the release of an all-in-one COVID-19 Virtual Patient Communication Kit that provides digital tools for screening and education in line with the Center for Disease Control’s (CDC) guidelines.
Each kit includes:
- AI-driven chatbots for instant engagement
- Video Conferencing to support telemedicine recommended by the CDC
- Secure Mobile Messaging
- Live Care Navigator Escalation
- Dynamic FAQ library including CDC/WHO resources
- Virtual deployment via QR Codes, SMS campaigns, or web/portal hosted widget
- White-labeled to support health system authority through brand awareness
- Mobile solution with no app download required
The kit allows patients to receive in-home advice and avoid emergency departments or clinics unless their condition warrants in-person care.
These secure tools allow patients to review science-sourced education from the CDC and World Health Organization and conduct personal risk assessments much like the clinical decision support programs used widely by clinicians today. Even if patients are asymptomatic and have no known exposure risks they’re better positioned with education and community resources.
“Virtual Communication Kits are the best way to combat the spread of virus while caring for the ones who are already infected,” said Krishna Kurapati, CEO and Founder of QliqSOFT, Inc.
Hospitals interested in QliqSOFT’s COVID-19 Virtual Patient Communication Kit should request more information here. Clinical Support Specialists are on standby to get the solution in place for health systems rapidly.
About QliqSOFT, Inc.
With its unique cloud pass-thru architecture, QliqSOFT’s Secure Texting, On-Call Scheduling, Patient Communication, and Clinical Collaboration solutions are trusted by over 1,000 Hospitals, Home Health, and Hospice Organizations to deliver HIPAA-compliant, reliable, and real-time communication between doctors, nurses, caregivers, and patients. To learn more, visit www.qliqsoft.com.
Saltidin® protects reliably against insects and ticks carrying the pathogens of dengue fever
Vector-borne diseases are on the rise. Among them, Dengue fever outbreaks are spreading alarmingly. Dengue is a mosquito-borne viral infection – transmitted by a day-biting mosquito, Aedes aegypti. The mosquito-borne disease is characterized by flu-like symptoms, which are particularly dangerous for children, pregnant women and the elderly.
Global expansion and distribution of Aedes mosquitoes have established dengue in tropical regions. ***Worldwide, the infections of dengue has increased 30-fold over the past 50 years. Of an estimated 2.5 billion people at risk for dengue globally, about 70% live in Asia Pacific countries. Climate conditions, unclean environments, unplanned urban settlements and rapid urbanization can lead to increased mosquito breeding.
For example, in the Philippines, the government declared the disease as a National Epidemic after having seen a dramatic outbreak last year with *370,000 registered infections of which 1,407 were lethal.
**Thailand is facing the largest dengue epidemic in more than two decades, with a record number of people infected. Thai health authorities have reported over 136.000 dengue patients, out of which 126 deaths were registered.
PREVENTION AND CONTROL
The following measures help to prevent mosquito bites indoors and outdoors:
- Wear light long-sleeved and bright-colored clothing.
- Use mosquito nets in front of the window or over your bed in an air-conditioned room.
- Eliminate stagnant water sources where female mosquitoes lay their eggs.
- Use insect repellents
INSECT REPELLENTS FOR PERSONAL USE
Applying insect repellents on skin is one of the most effective preventive measures. Insect repellents for personal use come in a variety of formulations, e.g. pump spray emulsions, gels, aerosols, wax sticks and wipes.
Saltidin®, also known by the names Picaridin and Icaridin, is an active ingredient for insect repellents that offers the perfect balance of efficacy, safety and user-friendliness.
- Long-lasting effective protection against mosquitoes that may transmit West Nile and Zika viruses and ticks that may transmit Lyme disease
- Safe toxicology profile with low skin absorption
- Good solubility
- High stability, non-corrosive and non-hazardous
- Colorless and odorless
- Excellent and pleasant cosmetic properties
- Non-sticky, non-greasy, and does not significantly attack common household materials including plastics, synthetics, coatings, foils and varnishes.
Saltidin® provides long-lasting, up to 12 hours protection (depending on the formulation) against:
- Mosquitoes that may transmit Dengue, West Nile Virus, Chikungunya or Zika
- Ticks that carry Lyme disease and tick-borneencephalitis
Also Saltidin® repels for up to eight hours:
- Biting flies
- Stable flies
- Black flies
- Sand flies
- Scottish biting midges
The toxicological profile of Saltidin® has been extensively evaluated following a program of protocols developed in close cooperation with the U.S. Environmental Protection Agency (EPA).
Dermal studies were conducted using Saltidin®-based products on the skin measuring dermal exposure. No adverse outcomes were identified in any studies in the program.
In the United States, insecticides are regulated by the U.S. EPA, which establishes strict standards for safety, effectiveness and product quality. Saltidin® was approvedas a repellent active ingredient by the U.S. EPA in 2001. Saltidin® is also approved by the Canadian Pest Management Regulatory Agency and recommended by the following institutions:
- World Health Organization (USA)
- Center for Disease Control and Prevention (USA)
- European Centre for Disease Prevention and Control
- Consumer Organization “Stiftung Warentest“ (Germany)
- Queensland Government Queensland Health (Australia)
- Swiss Tropical Institute (Switzerland)
- Advanced Pest Solutions at the University of Edinburgh‘s Biospace Incubator facility (Scotland)
*European Centre for Disease Prevention and Control (2019). Dengue worldwide overview. Accessed 2019/12/09: https://www.ecdc.europa.eu/en/dengue-monthly
**Samuitimes Newspaper (2019). Dengue Fever Outbreak. Accessed 2019/12/09: http://www.samuitimes.com/dengue-fever-outbreak/
***Nery, M. (2019). Dengue increase likely during rainy season: WHO warns. Accessed 2019/12/09: https://www.who.int/westernpacific/news/detail/11-06-2019-dengue-increase-likely-during-rainy-season-who-warn